Certolizumab pegol has a different profile from other anti-TNFs, including golimumab, in a variety of in vitro assays

Por Nesbitt A, Fossati G
Publicado em 2010-11-01

Certolizumab pegol has a different profile from other anti-TNFs, including golimumab, in a variety of in vitro assays

Por Fossati, G, Nesbitt, A
Publicado em 2010

Insoluble and soluble immune complexes activate neutrophils by distinct activation mechanisms: changes in functional responses induced by priming with cytokines

Por Fossati, G, Bucknall, R, Edwards, S
Publicado em 2002

Short term palindromic rheumatism after clopidogrel use

Por Ames, P R J, Fossati, G
Publicado em 2006

Immune Responses to Tumour and Embryo Cells in Patients with Mammary Carcinoma

Por Porta, G. Della, Canevari, S., Fossati, G.
Publicado em 1973

Allostimulation of patients' lymphocytes generates both T and NK-like cells cytotoxic for autologous melanoma.

Por Balsari, A., Fossati, G., Taramelli, D., Tona, G., Delia, D., Giardini, R., Parmiani, G.
Publicado em 1985

An immediate transcriptional signature associated with response to the histone deacetylase inhibitor Givinostat in T acute lymphoblastic leukemia xenografts

Por Pinazza, M, Borga, C, Agnusdei, V, Minuzzo, S, Fossati, G, Paganin, M, Michielotto, B, De Paoli, A, Basso, G, Amadori, A, te Kronnie, G, Indraccolo, S
Publicado no Cell Death Dis (2016)

Reduced SNAP-25 increases PSD-95 mobility and impairs spine morphogenesis

Por Fossati, G, Morini, R, Corradini, I, Antonucci, F, Trepte, P, Edry, E, Sharma, V, Papale, A, Pozzi, D, Defilippi, P, Meier, J C, Brambilla, R, Turco, E, Rosenblum, K, Wanker, E E, Ziv, N E, Menna, E, Matteoli, M
Publicado no Cell Death Differ (2015)